SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending following news of a $400 million AI partnership with Perplexity, combined with a $500 million stock buyback program and positive Q3 earnings results. The community is discussing whether this marks a true turnaround for the stock, with some anticipating a short squeeze while others remain skeptical of the company's long-term profitability.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

CELH is trending downwards, with community members expressing concerns about recent performance despite a reported earnings beat. Discussions center around a distributor termination charge impacting EPS, as well as potential channel stuffing and inventory issues. Some investors view the dip as a buying opportunity, citing long-term growth potential and Pepsi's increased involvement, while others are losing faith.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending amid a new partnership with ESPN, but community reactions are mixed, with some questioning the deal's impact and others hoping it will boost market share against competitors like FanDuel. Some traders are pointing to short squeeze potential, while others express concerns about upcoming earnings and competition from prediction markets. Community members are actively debating the financial implications of the ESPN deal and whether it will translate to long-term growth.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending due to investor frustration after earnings, with the community expressing disappointment over a lack of new partnerships and concerns about the CEO's strategy, especially regarding the CIC/Flu program. Many feel the company isn't prioritizing shareholder value, while others suggest a potential acquisition could be the best path forward amid skepticism about current management and execution.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo's stock is experiencing volatility amid discussions around its growth prospects and potential competition from AI-powered language learning tools. While some traders are betting on a rebound, others express concern about the company's valuation and future performance. Community members are actively debating the impact of AI on Duolingo's business model, with some suggesting AI could enhance its offerings.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix's stock is trending downwards as investors express frustration and distrust in management following repeated delays and missed deadlines, specifically regarding commercial smartphone production. The community is actively discussing the company's 2026 outlook, potential acquisitions, and the likelihood of securing purchase orders, with some expressing concern that competitors may catch up due to the delays, while others await CES for updates on smart eyewear products.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood's stock is trending as investors digest its latest earnings report, with some analysts raising price targets. Despite the positive outlook, the stock is experiencing volatility as the community debates whether the current valuation is justified and anticipates potential upgrades. Discussions also include the impact of prediction markets and potential partnerships.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending amid community excitement over the company's progress and potential profitability, with many highlighting the upcoming earnings report as a key catalyst. Discussions center on the growing revenue from Recorlev and the potential of other products, alongside optimism surrounding the company's technology platforms and potential acquisitions. Investors are closely watching for updates on collaborations and XP-8121, with some anticipating a significant rise in share price.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending as community members discuss its recent surge and potential as a privacy-focused alternative to Bitcoin. Some investors are taking profits from other cryptocurrencies like ETH and XRP to allocate to ZEC, while others are debating its actual utility and future price targets. Discussion includes ZEC's limited supply and potential to flip other cryptos.

Stagwell, Inc. operates as media and public relations agency. It delivers brands that connect culture-moving creativity with technology to harmonize the art and science of marketing. It operates through the following segments: Integrated Agencies Network, Brand Performance Network and Communications Network. The Integrated Agencies Network segment includes five operating segments: the Anomaly Alliance, Constellation, the Doner Partner Network, Code and Theory Network, and National Research Group. The Brand Performance Network consists of a single operating segment. BPN includes a unified media and data management structure with omnichannel media placement, creative media consulting, influencer and business-to-business marketing capabilities. The Communications Network reportable segment consists of a single operating segment, specialist network that provides advocacy, strategic corporate communications, investor relations, public relations, online fundraising and other services to both corporations and political and advocacy organizations and includes Allison, SKDK, Targeted Victory, and Consulum. The Corporate segment includes corporate office expenses. The company was founded on April 29, 2011 and is headquartered in New York, NY.

Stagwell Inc - Ordinary Shares - Class A

STGW is trending due to excitement around its partnership with PLTR to launch an AI-powered marketing platform, with community members expressing bullish sentiment and discussing potential price targets. Some traders are noting the high short interest and anticipating a squeeze, while others are wary of potential dilution or a pump and dump scheme. The company's fundamentals and debt levels are also being debated amid the increased volume.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance

SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance PR Newswire BOSTON and...

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025 SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025 PR Newswire BOSTON...

Tempus AI Stock Before Q3 Earnings Release: To Buy or Not to Buy?

TEM's 48% surge, key FDA clearances and bold AI acquisitions set the stage for its Q3 earnings reveal.

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan A.D.A.M. Innovations and SOPHiA GENETICS partner to advance...

SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology

SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in...

Strategic Partnerships Power Tempus AI's Healthcare Expansion

TEM deepens collaborations in oncology and neuroscience using its Lens and Next platforms to accelerate precision medicine.

Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold?

Tempus AI's soaring Q2 revenues, margin gains and near-EBITDA breakeven position it as a fast-rising force in precision medicine.

Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy?

TEM surged 34.5% in Q2 on AI-driven deals and product momentum, but valuation and profit concerns linger ahead of earnings.

TEM Shares Surge on New AI Breakthrough: Should Investors Jump In?

TEM stock rallies 7.3% after the FDA clears its second cardiology AI tool, witnessing a 48% surge in just three months.

Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today?

SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.

Current Price	$4.56
Prev Close	$4.52
Open	$4.56
Dividend Yield	N/A
50-Day Moving Average	$3.97
Beta	0.99
Avg. Volume	134,788.74
PE Ratio	-4.05

52-Week High	$5.30
52-Week Low	$2.58
Market Capitalization	$305.46M
EPS (Annual)	-$0.946
Price to Book	5.05
Revenue Per Employee	$154,073.29
Enterprise Value/EBITDA	N/A

SOPH
SOPHiA Genetics SA

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SOPH News

SOPHSOPHiA Genetics SA